Kazda S, Müller W, Böhme A, Cleve H, Schönitzer D, Reissigl H, Weiser G
Padiatr Padol. 1982;17(4):695-704.
A report on 9 cases of infantile hepatopathy and cirrhosis of the liver respectively in cases of hereditary autosome-recessive alpha 1-antitrypsin deficiency (alpha 1-ATM). The genetic variants of the serum-protease-inhibitor (Pi) alpha 1-antitrypsin (alpha 1-AT) were examined by means of iso-electric focusing (Polyacrylamidgelen). The gene incidence was of the allel PiZ 0,0138 in the 868 blood donors from the Tyrol and was therefore within the range of the PiZ-frequencies seen in other Central-European populations. The other alleles PiM1, PiM2, PiM3, and PiS, point to the incidence of 0.7062, 0.1480, 0.1037, and 0.0225. The patients under observation (9) are homozygote PiZZ, the clinically healthy parents heterozygote PiZM. Risk of repetition in siblings of the patients is 25%. Early indicative symptoms are prolonged jaundice, acholic stools and hepatomegaly. Further developments are the fading of the hyperbilirubinaemia, temporary improvement in the pathological liver values, a freedom of symptoms for different lengths of time in each case, in the case of two patients, finally, decompensated cirrhosis of the liver and death in hepatic coma. The histological picture of the liver tissue shows PAS-positive storage granula in hepatozytes, intrahepatic hypoplasia of the bile duct, cholestasis as well as early cell necrobiosis, fibrosis and cirrhotic transformation. Course and severity of the liver complaint differ greatly, and are independent of the quantitative alpha 1-antitrypsin deficiency revealed, treatment is purely symptomatic.
一份关于9例遗传性常染色体隐性α1 -抗胰蛋白酶缺乏症(α1 - ATM)导致的婴儿肝病和肝硬化病例的报告。通过等电聚焦法(聚丙烯酰胺凝胶)检测血清蛋白酶抑制剂(Pi)α1 -抗胰蛋白酶(α1 - AT)的基因变异。在来自蒂罗尔州的868名献血者中,等位基因PiZ的基因发生率为0.0138,因此处于其他中欧人群所见的PiZ频率范围内。其他等位基因PiM1、PiM2、PiM3和PiS的发生率分别为0.7062、0.1480、0.1037和0.0225。观察的患者(9例)为纯合子PiZZ,临床健康的父母为杂合子PiZM。患者兄弟姐妹中疾病复发风险为25%。早期指示性症状为黄疸持续时间延长、无胆汁粪便和肝肿大。进一步发展为高胆红素血症消退、肝脏病理值暂时改善、每种情况下症状在不同时间段内缓解,在两名患者中,最终发展为失代偿性肝硬化并死于肝昏迷。肝组织的组织学表现为肝细胞内PAS阳性储存颗粒、肝内胆管发育不全、胆汁淤积以及早期细胞坏死、纤维化和肝硬化转变。肝脏疾病的病程和严重程度差异很大,且与所揭示的α1 -抗胰蛋白酶缺乏的定量无关,治疗纯属对症治疗。